Nachrichten zur AstraZeneca PLC Aktie

AstraZenecas drug pipeine is splitting opinion among City analysts

AstraZeneca PLC (LSE:AZN, NASDAQ:AZN) drug pipeline is splitting opinion among City brokers, with Citibank upgrading its price target to 17,800p...…

The Zacks Analyst Blog Highlights Apple, Microsoft, Amazon, LVMH, AstraZeneca, Shell, Airbus and UBS

AAPL, MSFT and AMZN earnings join key central bank meetings as investors track AI spending, interest rates and rising geopolitical…

AstraZeneca: Q2 2026 Results Were All Right, But Farxiga Poses Risks

…

Omeros gains as AstraZenecas Ultomiris fails in rare blood disorder

…

Astrazeneca (AZN) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates

While the top- and bottom-line numbers for Astrazeneca (AZN) give a sense of how the business performed in the quarter…

FTSE 100 gains as Vodafone and AstraZeneca impress

The FTSE 100 rose on Monday as traders reacted positively to a break in fighting in the Middle East, which…

Krebsmittel treiben Wachstum von Astrazeneca an - Aktie steigt

LONDON (dpa-AFX) - Der Pharmakonzern Astrazeneca hat im zweiten Quartal zugelegt. So stieg der Umsatz…

AstraZeneca shares climbs as full-year outlook reiterated despite recent trial failure

AstraZeneca PLC (LSE:AZN, NASDAQ:AZN) shares climbed to their highest in over two weeks after the drugmaker reported better second-quarter earnings than...…

AstraZeneca earnings beat forecasts despite slight revenue miss

AstraZeneca PLC (LSE:AZN, NASDAQ:AZN) reported better second-quarter earnings than expected as growth in oncology and rare diseases helped offset weaker...…

AstraZeneca shares climbs as full-year outlook reiterated despite recent trial failure

AstraZeneca PLC (LSE:AZN, NASDAQ:AZN) shares climbed to their highest in over two weeks after the drugmaker reported better second-quarter earnings than...…

FTSE 100 Live: Strong start expected to busy week as AstraZeneca, Vodafone report results

FTSE 100 Live: Flying start expected to busy week The FTSE 100 is set to hit the ground running on…

FTSE 100 Live: Stocks advance as oil price retreats, Chinas new chip champion IPOs

FTSE 100 up 40 points at 10,777 Oil prices drop as US and Iran pause strikes AstraZeneca and Vodafone report as…

FTSE 100 Live: Stocks advance as oil price retreats, oil falls below $90

FTSE 100 up 40 points at 10,777 Oil prices drop as US and Iran pause strikes AstraZeneca and Vodafone report as…

FTSE 100 Live: Stocks start higher as oil price tumbles, Vodafone and AstraZeneca impress

8.15am: FTSE 100 springs higher at open, led by Vodafone The FTSE 100 has begun the week with a spring…

FTSE 100 Live: Stocks advance as oil price retreats, retail downturn eases

FTSE 100 up 40 points at 10,777 Oil prices drop as US and Iran pause strikes AstraZeneca and Vodafone report as…

AstraZeneca reiterates annual guidance after topping Q2 profit expectations

AstraZeneca reiterates annual guidance after topping Q2 profit expectations…

AstraZeneca magic faces rare test after trial failure, share slide

AstraZenecas long-time CEO Pascal Soriot has rarely put a foot wrong. The companys shares have more that quadrupled in price…

Jefferies says September lung data can offset AstraZeneca trial failure

Jefferies believes detailed data on AstraZeneca PLCs (LSE:AZN, NASDAQ:AZN) experimental lung drug tozorakimab could more than compensate investors for the...…

Astrazeneca (AZN) Falls More Steeply Than Broader Market: What Investors Need to Know

Astrazeneca (AZN) closed the most recent trading day at $164.52, moving 2.59% from the previous trading session.…

AstraZenecas Oncology Engine Keeps Running Despite Wainua Setback

…

AstraZeneca to pay up to $1.5bn for global rights to lung cancer pill

AstraZeneca PLC (LSE:AZN, NASDAQ:AZN) has agreed to pay $600 million upfront to secure worldwide rights to a lung cancer pill developed…

HSBC downgrades AstraZeneca after key trial failure

HSBC has downgraded AstraZeneca PLC (LSE:AZN, NASDAQ:AZN) to hold from buy, arguing that a recent trial failure has removed the central…

UBS stays positive on AstraZeneca ahead of second-quarter results

UBS expects AstraZeneca PLC (LSE:AZN, NASDAQ:AZN) to report solid second-quarter results later this month, though it sees little room for the…

DEUTSCHE BANK RESEARCH stuft ASTRAZENECA auf Sell

FRANKFURT (dpa-AFX Analyser) - Deutsche Bank Research hat die Einstufung für Astrazeneca mit einem Kursziel von 11500 Pence auf "Sell"…

UBS stuft ASTRAZENECA auf Buy

ZÜRICH (dpa-AFX Analyser) - Die Schweizer Großbank UBS hat die Einstufung für Astrazeneca mit einem Kursziel von 17600 Pence auf…

AstraZeneca erases billions after sobering reveal

Drug trials fail all the time. What is rare is a failure that costs a company tens of billions of…

AstraZenecas trial flop raises a bigger question: Is its pipeline premium becoming more vulnerable?

For years, AstraZeneca has commanded one of the richest valuations among large European pharma companies on the assumption that it…

Astrazeneca (AZN) Stock Dips While Market Gains: Key Facts

The latest trading day saw Astrazeneca (AZN) settling at $171.61, representing a -3.85% change from its previous close.…

AstraZeneca And Ionis Pharma Rocked By Heart Disease Fail: Why You Shouldnt Panic

…

AstraZenecas Wainua failure hurts credibility more than valuation, Jefferies warns

The damage to AstraZeneca PLC (LSE:AZN, NASDAQ:AZN) from Wainuas trial failure is less about the numbers than about a dent…

AstraZenecas Wainua failure hurts credibility more than valuation, Jefferies warns

The damage to AstraZeneca PLC (LSE:AZN, NASDAQ:AZN) from Wainuas trial failure is less about the numbers than about a dent…

AstraZenecas Rare Drug Trial Failure Sends Shares Plunging

AstraZeneca Plcs shares dropped more than 10% after a trial of a new heart drug failed to help prevent heart…

AstraZenecas Stock Drops on Wainuas Setback in ATTR-CM Study

AZN shares tumble after Wainua missed the primary endpoint in a late-stage ATTR-CM study, raising questions about its expansion into…

Opening Bell: Wall Street startet im Plus; AstraZeneca, PepsiCo, Fuelcell Energy, Arista Networks. ...

Trotz zunehmender militärischer Auseinandersetzungen zwischen den USA und dem Iran werden die US-Aktienmärkte am Donnerstag moderat im Plus erwartet. Eine…

AstraZeneca stock drops 9% after heart drug trial miss deals rare blow to pharma powerhouse

A late-stage clinical trial failed to miss its primary endpoint, U.K.s laregst drugmaker said Thursday.…

Stocks making the biggest moves premarket: AstraZeneca, PepsiCo, Salesforce, Levi & more

These are the stocks posting the largest moves in the premarket.…

FTSE 100 dragged lower by AstraZeneca

The FTSE 100 fell on Thursday as AstraZeneca dragged the index lower after releasing disappointing trial results for a cardiovascular drug.…

AstraZeneca sees stock market value slump by more than £20bn after drug setback

The FTSE 100 firm found the Wainua drug failed to meet a goal to reduce deaths related to heart disease.…

Astrazeneca-Kandidat Wainua verfehlt Ziel in klinischer Studie - Aktie sackt ab

LONDON (dpa-AFX) - Der Astrazeneca-Hoffnungsträger Wainua hat in einer klinischen Studie enttäuscht. In der Phase-3-Studie verfehlte…

AstraZenecas £19bn blow as Wainua heart drug fails key late-stage trial

AstraZeneca PLC (LSE:AZN, NASDAQ:AZN) shares fell 9.55% in early trading, wiping £19 billion from the companys valuation, after its Wainua drug…

AstraZenecas £19bn blow as Wainua heart drug fails key late-stage trial

AstraZeneca PLC (LSE:AZN, NASDAQ:AZN) shares fell 9.55% in early trading, wiping £19 billion from the companys valuation, after its Wainua drug…

FTSE 100 Live: AstraZeneca exerts big drag, Computacenter and Playtech soar

FTSE 100 down 49 points to 10,440 AstraZeneca tumbles after clinical trial failure Computacenter and Playtech soar after trading updates  2.29pm:…

FTSE 100 Live: AstraZeneca drags while Computacenter soars, US AI stocks gain

FTSE 100 down 39 points to 10,450 AstraZeneca tumbles after clinical trial failure Computacenter and Playtech soar after trading updates  2.42pm:…

FTSE 100 Live: London index hit by AstraZeneca failure, Computacenter and Playtech soar

FTSE 100 down 61 points to  AstraZeneca tumbles after clinical trial failure Computacenter and Playtech soar after trading updates 10.26am: Playtech…

FTSE 100 Live: Index opens lower after AstraZeneca trial failure, Computacenter surges

8.14am: AstraZeneca drags FTSE into red The FTSE 100 opened higher in the first two minutes of trading but has…

FTSE 100 Live: London index stands alone in red after AstraZeneca trial failure

9.31am: European markets rebound, apart from the FTSE After an hour and a half of trading, European markets are broadly higher,…

AstraZeneca Aktie: Kaufchance - trotz gesenktem Kursziel!

London (www.aktiencheck.de) - AstraZeneca-Aktienanalyse von HSBC:Die HSBC habe das Kursziel für die Aktie von AstraZeneca plc (ISIN: GB0009895292, WKN: 886455,…

Pfizer or AstraZeneca: Which Stock Offers Better Long-Term Potential?

AZN targets continued 2026 growth with expanding blockbuster medicines, a strong pipeline and 2030 revenue goals as it outpaces Pfizer…

AstraZeneca PLC (AZN) Discusses Progress in Sustainability Strategy and the Role of AI in Healthcare Innovation Transcript

…

Citi keeps AstraZeneca on buy ahead of second-quarter results

AstraZeneca PLC (LSE:AZN, NASDAQ:AZN) has been kept on a buy rating by Citi, which pointed to a run of late-stage drug…